Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
1.180
+0.020 (1.72%)
Jul 10, 2025, 4:00 PM - Market closed
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $26.41 million as of July 11, 2025. Its market cap has decreased by -78.06% in one year.
Market Cap
26.41M
Enterprise Value
-63.27M
1-Year Change
-78.06%
Ranking
Category
Stock Price
$1.18
Market Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $26.41M, a decrease of -92.58%. That is a compound annual growth rate of -86.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 26.41M | -59.15% |
| Dec 31, 2024 | 64.67M | -81.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.45B |
| Johnson & Johnson | 376.02B |
| AbbVie | 336.71B |
| Novo Nordisk | 308.58B |
| UnitedHealth Group | 274.78B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 231.78B |
| AstraZeneca | 218.25B |